Literature DB >> 7591966

Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine.

M Kawada1, K Umezawa.   

Abstract

The mechanism of inostamycin action was further studied. When multidrug-resistant KB-C4 cells were preincubated with inostamycin for 30 min, the accumulation of [3H]vinblastine was increased for as long as 48 h thereafter. Inostamycin inhibited azidopine binding to P-glycoprotein, even after KB plasma membranes had been preincubated with inostamycin and washed. Carbon 14-labeled inostamycin bound to KB plasma membranes irreversibly, but the binding capacity did not parallel the amount of P-glycoprotein in three KB cell lines. Inostamycin was found to interact specifically with purified phosphatidylethanolamine. These results suggest that inostamycin can inhibit P-glycoprotein irreversibly by binding to plasma membranes irreversibly through phosphatidylethanolamine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591966      PMCID: PMC5920936          DOI: 10.1111/j.1349-7006.1995.tb03099.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

Review 1.  Is the multidrug transporter a flippase?

Authors:  C F Higgins; M M Gottesman
Journal:  Trends Biochem Sci       Date:  1992-01       Impact factor: 13.807

2.  Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

Authors:  K Yusa; T Tsuruo
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

3.  Isolation and expression of a complementary DNA that confers multidrug resistance.

Authors:  P Gros; Y B Ben Neriah; J M Croop; D E Housman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

4.  Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

Authors:  J J Smit; A H Schinkel; R P Oude Elferink; A K Groen; E Wagenaar; L van Deemter; C A Mol; R Ottenhoff; N M van der Lugt; M A van Roon
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

5.  The effects of lipids and detergents on ATPase-active P-glycoprotein.

Authors:  C A Doige; X Yu; F J Sharom
Journal:  Biochim Biophys Acta       Date:  1993-02-23

6.  Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

Authors:  A Fojo; S Akiyama; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

7.  Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

Authors:  S Ruetz; P Gros
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

8.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

9.  Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.

Authors:  M M Cornwell; A R Safa; R L Felsted; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Long-lasting accumulation of vinblastine in inostamycin-treated multidrug-resistant KB cells.

Authors:  M Kawada; K Umezawa
Journal:  Jpn J Cancer Res       Date:  1991-10
View more
  1 in total

1.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.